GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

2,201.00p
   
  • Change Today:
      34.00p
  • 52 Week High: 2,268.00
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,072.56m
  • Volume: 13,807,652
  • Market Cap: £89,637m
  • RiskGrade: 129
  • Beta: 0.00

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 24,696.00 3,599.00 90.56p 22.2 n/a -22% 80.00p 4.0%
31-Dec-22 29,324.00 5,628.00 139.70p 10.3 0.2 +54% 44.00p 3.1%
31-Dec-23 30,328.00 6,064.00 155.10p 9.4 0.9 +11% 58.00p 4.0%
31-Dec-24 31,376.00 3,477.00 159.30p 8.5 2.8 +3% 61.00p 4.5%
31-Dec-25 32,667.00 7,401.00 172.00p 10.6 1.3 +8% 66.00p 3.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 33,848.41 9,763.76 181.46p 12.2 2.2 +6% 70.49p 0.0%
31-Dec-27 35,517.27 10,468.76 196.57p 11.3 1.4 +8% 74.80p 0.0%
31-Dec-28 36,611.60 10,790.99 204.88p 10.8 2.6 +4% 79.71p 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 22.18 8.45 12.18 1.05

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

GSK Market Data

Currency UK Pounds
Share Price 2,201.00p
Change Today 34.00p
% Change 1.57 %
52 Week High 2,268.00
52 Week Low 1,264.00
Volume 13,807,652
Shares Issued 4,072.56m
Market Cap £89,637m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 13
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 19-Feb-26 13-Nov-25
Paid 09-Apr-26 08-Jan-26
Amount 18.00p 16.00p

Trades for 27-Feb-2026

Time Volume / Share Price
16:24 1 @ 2,197.00p
16:20 0 @ 2,194.00p
15:43 1 @ 2,191.00p
15:42 0 @ 2,191.00p
15:28 0 @ 2,187.00p

GSK Key Personnel

CEO Luke Miels

Top of Page